Cited Research
- AAD — Xanthelasma ncbi.nlm.nih.gov
- PubMed — Xanthelasma and cardiovascular risk pubmed.ncbi.nlm.nih.gov
Xanthelasma palpebrarum are soft, yellowish, cholesterol-filled plaques that typically appear on the inner upper eyelids. They are most often benign cosmetically but, as published in a landmark BMJ study, are independently associated with increased cardiovascular risk even when serum lipids are normal.
The two-conversation rule
Every patient who comes to us for xanthelasma removal leaves with a second piece of advice: book a lipid panel and a primary-care visit. The cosmetic problem and the systemic signal are addressed separately and equally.
Treatment options
- Surgical excision — the gold standard for small to medium plaques; precise scar control on the eyelid.
- Erbium / CO2 laser — excellent for diffuse plaques; minimal scarring.
- Trichloroacetic acid (TCA) — chemical option for thin lesions.
- Cryotherapy — historical, less precise on the eyelid.
Recurrence is common — and manageable
Up to 40% of treated patients will see some recurrence over years, particularly if underlying lipid metabolism is uncorrected. This is not a failure of treatment; it is a feature of the condition.
References & Further Reading
This article is general information about procedures we perform. It is not medical advice and does not replace an assessment by a physician who has examined you. Individual results, risks and recovery vary.